Should You Accumulate Arena Pharmaceuticals, Inc. (ARNA) Stock Thursday?

Thursday, October 28, 2021 10:39 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Arena Pharmaceuticals, Inc. (ARNA) Stock Thursday?

Arena Pharmaceuticals, Inc. (ARNA) stock has fallen -31.84% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 33 out of a possible 100. That rank is mainly influenced by a short-term technical score of 12. ARNA's rank also includes a long-term technical score of 12. The fundamental score for ARNA is 74. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $97.43. This means analysts expect the stock to increase 71.38% over the next 12 months.

ARNA has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

What's Happening with ARNA Stock Today

Arena Pharmaceuticals, Inc. (ARNA) stock is up 2.43% while the S&P 500 is up 0.75% as of 10:38 AM on Thursday, Oct 28. ARNA is up $1.35 from the previous closing price of $55.50 on volume of 531,019 shares. Over the past year the S&P 500 is higher by 40.19% while ARNA has fallen -31.84%. ARNA lost -$8.17 per share in the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.